Inventor · disambiguated record
William Larochelle
Also filed as: LAROCHELLE WILLIAM · LAROCHELLE WILLIAM J
12 granted patents·32 pending applications·195 citations·filing 1993–2017
92Inventor score
Top patents by PatentIndex Score
44 records- 0187US6368828B1Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and Stat6cUS HEALTH·Filed 2000·Granted Apr 9, 2002·17 cites·35 claims
- 0281US5468468AMethod for making a monoclonal antibody, monoclonal antibodies to α PDUS HEALTH·Filed 1993·Granted Nov 21, 1995·36 cites·15 claims
- 0380US8846873B2Antibodies directed to GPNMB and uses thereofXIAO FENG·Filed 2012·Granted Sep 30, 2014·9 cites·27 claims
- 0480US5833986AMethods of inhibiting the growth of neoplasia using a monoclonal antibody against α platelet derived growth factor receptorUS HEALTH·Filed 1995·Granted Nov 10, 1998·27 cites·2 claims
- 0579US6403769B1Fusion proteins that include antibody and nonantibody portionsUS HEALTH·Filed 1996·Granted Jun 11, 2002·44 cites·5 claims
- 0678US6863889B2Polynucleotides and proteins encoded therebyCURAGEN CORP·Filed 2001·Granted Mar 8, 2005·6 cites·1 claims
- 0774US7253266B2Polypeptides of FGF-CXCURAGEN CORP·Filed 2002·Granted Aug 7, 2007·5 cites·11 claims
- 0874US7189693B2Treatment of inflammatory bowel disease using fibroblast growth factor CX polypeptidesCURAGEN CORP·Filed 2002·Granted Mar 13, 2007·4 cites·26 claims
- 0973US7056885B1Fibroblast growth factor and nucleic acids encoding sameCURAGEN CORP·Filed 2000·Granted Jun 6, 2006·7 cites·6 claims
- 1072US5998598AImmunoadhesins and methods of production and use thereofUS ARMY·Filed 1997·Granted Dec 7, 1999·27 cites·2 claims
- 1166US2014314780A1Compositions Using Antibodies Directed to GPNMB and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1263US5863739AAssay and kit for the detection of α platelet derived growth factor receptorUS HEALTH·Filed 1995·Granted Jan 26, 1999·10 cites·2 claims
- 1361US2018043014A1Compositions Using Antibodies Directed to GPNMB and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1459US2013156784A1Compositions Using Antibodies Directed To GPNMB And Uses ThereofJEFFERS MICHAEL·Filed 2012·Application pending·0 cites
- 1555US2015044212A1Antibodies Directed to GPNMB and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1655US2005164929A1Methods of preventing and treating inflammatory bowel diseaseLUPINE LOGIC INC·Filed 2004·Application pending·0 cites
- 1753US2005208514A1Novel fibroblast growth factor and nucleic acids encoding dameALSOBROOK JOHN II·Filed 2004·Application pending·0 cites
- 1852US2005063971A1Antibodies to fibroblast growth factor and their methods of useCURAGEN CORP·Filed 2004·Application pending·0 cites
- 1952US2005256042A1Methods of preventing and treating alimentary mucositisJEFFERS MICHAEL E·Filed 2004·Application pending·0 cites
- 2050US2003224991A1Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesisFiled 2003·Application pending·0 cites
- 2150US2005142137A1Antibodies against secretoryleukocyte protease inhibitorCURAGEN CORP·Filed 2004·Application pending·0 cites
- 2249US2005191681A1Novel polynucleotides and proteins encoded therebyCURAGEN CORP·Filed 2005·Application pending·0 cites
- 2348US2005256039A1Novel fibroblast growth factors and methods of use thereofPETERSON JEFFERY·Filed 2004·Application pending·0 cites
- 2448US2006234255A1Novel proteins and nucleic acids encoding samePENA CAROL E·Filed 2006·Application pending·0 cites
- 2547US2016311919A1Antibodies Directed To GPNMB And Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2647US2004029150A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2003·Application pending·0 cites
- 2747US2013202527A1Method of Treating Ovarian and Renal Cancer Using Antibodies Against T Cell Immunoglobulin Domain And Mucin Domain 1 (TIM-1) AntigenCELLDEX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2846US2006084054A1Novel proteins and nucleic acids encoding sameALSOBROOK JOHN·Filed 2003·Application pending·0 cites
- 2945US2004018977A1Semaphorin-like proteins and methods of using sameFiled 2003·Application pending·0 cites
- 3044US2017267750A1Method of Treating Ovarian and Renal Cancer Using Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) AntigenCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3144US2008287349A1Fibroblast growth factor 20 and methods of use thereofPETERSON JEFFREY·Filed 2004·Application pending·0 cites
- 3244US2004141969A1Method for the treatment of nephritis using anti-PDGF-DD antibodiesFiled 2003·Application pending·0 cites
- 3343US2002058036A1Novel fibroblast growth factor and nucleic acids encoding sameFiled 2001·Application pending·0 cites
- 3443US2004018199A1Compositions and methods of use for an ephrin receptorFiled 2003·Application pending·0 cites
- 3543US2004002120A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2002·Application pending·0 cites
- 3642US2007098715A1Antibodies against the tenascin major antigensETTENBERG SETH·Filed 2006·Application pending·0 cites
- 3742US2004058338A1Novel proteins and nucleic acids encoding sameFiled 2002·Application pending·0 cites
- 3840US2004214759A1Compositions and methods of use for a fibroblast growth factorFiled 2003·Application pending·0 cites
- 3938US2013244255A1Antibodies directed to gpnmb and uses thereofPOLLACK VINCENT A·Filed 2012·Application pending·0 cites
- 4038US2006094647A1Treatment of inflammatory bowel disease using growth factorsJEFFERS MICHAEL E·Filed 2001·Application pending·0 cites
- 4137US5573935AProtein tyrosine kinase A6US ARMY·Filed 1994·Granted Nov 12, 1996·3 cites·10 claims
- 4237US2004067490A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2002·Application pending·0 cites
- 4336US2006211031A1Novel proteins and nucleic acids encoding sameZHONG HAIHONG·Filed 2006·Application pending·0 cites
- 4435US2006210559A1Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of useLAROCHELLE WILLIAM·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →